Table 2.
Characteristics of Participants With or Without Exaggerated Aortic Stiffness (Defined as PWV >10 m/s) at Their Study Entry
| PWV ≤10 m/s at Baseline (n = 5514) | PWV > 10 m/s at Baseline (n = 497) | |
|---|---|---|
| Age, y, mean ± SD | 41.3 ± 16.3 | 67.2 ± 11.9 |
| Age group, n (%) | ||
| <35 y | 2117 (38.4) | 10 (2.0) |
| 35–49 y | 1688 (30.6) | 29 (5.9) |
| 50–64 y | 1152 (20.9) | 146 (29.4) |
| ≥65 y | 557 (10.1) | 312 (62.7) |
| Women | 3219 (57.8) | 279 (55.7) |
| BMI | 25.0 ± 4.5 | 29.0 ± 4.9 |
| Waist circumference, cm | 83.6 ± 12.5 | 96.1 ± 12.3 |
| Fasting glucose, mg/dL | 88.4 ± 21 | 105.9 ± 35.4 |
| Total cholesterol, mg/dL | 206.7 ± 41.7 | 227.2 ± 43.8 |
| HDL cholesterol, mg/dL | 64 ± 14.9 | 65.5 ± 14.7 |
| LDL cholesterol, mg/dL | 125.6 ± 35.0 | 139.0 ± 37.8 |
| Triglycerides, mg/dL | 85.7 ± 66.4 | 113.2 ± 79.3 |
| Serum creatinine, mg/mL | 0.80 ± 0.19 | 0.85 ± 0.36 |
| SBP, mmHg | 123.6 ± 16.9 | 147.6 ± 21.0 |
| DBP, mmHg | 76.3 ± 10.5 | 84.7 ± 11.5 |
| MBP, mmHg | 91.9 ±11.7 | 105.5 ± 13.2 |
| PP, mmHg | 47.3 ± 11.7 | 62.9 ± 16.4 |
| NT | 75.7 | 22.0 |
| HT, treated and controlled | 3.1 | 8.2 |
| HT, treated and not controlled | 16.9 | 47.4 |
| HT, untreated and not controlled | 4.3 | 22.4 |
BMI, body mass index; HDL, high-density lipoprotein; HT, hypertensive; LDL, low-density lipoprotein; NT, normotensive; PP, pulse pressure.
Unless otherwise noted, values are mean ± SD.